Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodside Energy Regulatory News (WDS)

  • There is currently no data for WDS

Further re Dividend

14 Mar 2023 07:07

RNS Number : 8793S
Woodside Energy Group Ltd
14 March 2023
 

Woodside Energy Group Ltd

ACN 004 898 962

Mia Yellagonga

11 Mount Street

Perth WA 6000

Australia

T +61 8 9348 4000

www.woodside.com

 

ASX: WDS

NYSE: WDS

LSE: WDS

 Announcement

Tuesday, 14 March 2023

2022 FINAL DIVIDEND CURRENCY EXCHANGE RATES

On 27 February 2023, Woodside Energy Group Ltd (Woodside) declared a fully franked final dividend of 144 US cents per share in respect of the six month period ended 31 December 2022 (the Final Dividend). As previously announced, the record date for the Final Dividend was 9 March 2023 and the payment date is 5 April 2023.

Woodside dividends are determined and declared in US dollars.

The US cent currency exchange rate applicable to the dividend payable in Australian dollars, British pounds sterling and New Zealand dollars is determined based on the foreign currency rates prevailing on or around the record date of 9 March 2023.

The amount payable in Australian dollars, British pounds sterling and New Zealand dollars is detailed below:

Currency

Exchange rate

Dividend per share in local currency

AUD - Australian dollar

0.668400

2.15439856

GBP - Pound Sterling

1.185020

1.21516936

NZD - New Zealand dollar

0.612200

2.35217249

 

Shareholders will receive their dividend in Australian dollars unless their registered address is in the United Kingdom (in which case they will receive their dividend in British pounds sterling), in the United States of America (in which case they will receive their dividend in US dollars) or in New Zealand (in which case they will receive their dividend in NZ dollars).

 

Shareholders should contact the Woodside share registry if they wish to alter their dividend currency for future dividend payments. Contact details are available Woodside website on the Shareholder Information section of the Investors page.

As announced on 27 February 2023, the Woodside dividend reinvestment plan has been suspended and therefore is not available in relation to the Final Dividend.

 Contacts: 

 

 

INVESTORS

Matthew Turnbull

M: +1 (713) 448-0956

Sarah Peyman

M: +61 457 513 249

 E: investor@woodside.com

MEDIA

 Christine Forster

M: +61 484 112 469

E: christine.forster@woodside.com

 

 

This announcement was approved and authorised for release by Woodside's Disclosure Committee.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FUREAXDLFELDEEA
Date   Source Headline
24th Jan 20247:00 amRNSFourth Quarter 2023 Report
7th Dec 20238:12 amRNSResponse to media speculation
6th Dec 20237:00 amRNSWDS and Mexico Pacific sign LNG supply agreement
8th Nov 20237:00 amRNSInvestor Briefing Day 2023
18th Oct 20237:00 amRNSThird Quarter 2023 Report
7th Sep 20237:00 amRNSFurther re interim dividend
4th Sep 202310:29 amRNSDirector/PDMR Shareholding
4th Sep 202310:26 amRNSDirector/PDMR Shareholding
4th Sep 202310:21 amRNSDirector/PDMR Shareholding
30th Aug 20237:48 amRNSFurther re Trion development
23rd Aug 20237:00 amRNSHalf-Year 2023 Results Briefing Transcript
22nd Aug 20237:00 amRNSHalf-Year 2023 Results Briefing Presentation
22nd Aug 20237:00 amRNSHalf-Year 2023 Report
8th Aug 20238:07 amRNSWDS to sell 10% Scarborough interest to LNG Japan
19th Jul 20237:00 amRNSSecond Quarter 2023 Report
18th Jul 20237:00 amRNSSangomar project update
30th Jun 20237:51 amRNSReport on payments to governments 2022
20th Jun 20237:54 amRNSWoodside approves investment in Trion development
2nd Jun 202311:24 amRNSFatality at North Rankin Complex
4th May 20239:11 amRNSWDS TR-1: Notification of major holdings
4th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNS2023 Annual General Meeting voting results
28th Apr 20237:00 amRNSAGM Address by Chair R. Goyder and CEO M. O'Neill
27th Apr 20237:00 amRNSAppointment of EVP Australian Operations
21st Apr 20237:00 amRNSFirst Quarter 2023 Report
20th Mar 20237:00 amRNSNotice of Annual General Meeting 2023
14th Mar 20237:07 amRNSFurther re Dividend
9th Mar 202312:44 pmRNSDirector/PDMR Shareholding
9th Mar 202312:42 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSChanges to Woodside Board
3rd Mar 202312:29 pmRNSDirector/PDMR Shareholding Director/CEO
3rd Mar 20237:00 amRNSPDMR Notification Non-Executive Directors
1st Mar 20238:42 amRNSFull-Year 2022 Results Briefing Transcript
27th Feb 20237:00 amRNSFinal Dividend Announcement
27th Feb 20237:00 amRNSFull-Year 2022 Results
27th Feb 20237:00 amRNSWoodside - Publication Announcement
23rd Feb 20237:00 amRNSResolutions under s249N of the Corporations Act
14th Feb 20237:00 amRNSLine-item guidance and other items
13th Feb 20237:00 amRNSAnnual General Meeting 2023
9th Feb 20238:51 amRNSHolding(s) in Company
25th Jan 20237:00 amRNSFourth Quarter 2022 Report
12th Dec 20229:47 amRNSRevised Securities Dealing Policy
1st Dec 20227:00 amRNSInvestor Briefing Day 2022
29th Nov 20227:00 amRNSEVP Australian Operations Resignation
29th Nov 20227:00 amRNS2023 full-year guidance
7th Nov 20228:05 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSThird Quarter 2022 Report
20th Oct 20227:00 amRNSCompany Secretary Change
14th Sep 20229:22 amRNSFurther re 2022 Interim Dividend
6th Sep 20229:40 amRNSPDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.